Quest Diagnostics Inc. (DGX) on Thursday reaffirmed its guidance for its results from continuing operations, before special items, for the full year 2013.
The company said it continues to expect full year 2013 revenues to approximate the prior-year level and full year adjusted earnings to be $4.35 to $4.55 per share.
Analysts polled by Thomson Reuters currently expect the company to earn $4.35 per share on revenue of $7.31 billion for the full year 2013. Analysts' estimates typically exclude special items.
In his remarks during a presentation at the Jefferies 2013 Global Healthcare Conference in New York City, Steve Rusckowski, Quest Diagnostics President and CEO, said, "We remain comfortable with our guidance for the full-year 2013 as we are making good progress on all five points of our business strategy. As we've said, 2013 is a building year and we expect to see improvements in revenues and earnings versus the prior year starting in the second half. Second quarter revenues and earnings are expected to be down versus the prior year, but improved compared to first quarter results."
Separately, the company said that it is making progress in the search for a new Chief Financial Officer. Robert Hagemann, Senior Vice President and CFO, has agreed to delay his departure previously planned for May 31 to assist with the transition, the company noted.
For comments and feedback: editorial@rttnews.com